{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:30:15Z","timestamp":1786491015514,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":112,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fibrous dysplasia (FD) of bone is a fibro-osseous disorder caused by GNAS mutations with defective osteogenic differentiation and increased bone remodeling activity. Inhibition of RANKL leads to the replacement of FD lesions with bone. However, the mechanism and pattern of deposition of the newly formed bone remain unclear. Here, we perform morphological and molecular analyses on EF1\u03b1-Gs\u03b1\n                    <jats:sup>R201C<\/jats:sup>\n                    (FD) mice receiving an anti-mouse RANKL antibody. We show that, although the treatment reduces the expression of osteogenic genes, osteoblastic cells continue to produce bone matrix within FD lesions. However, bone formation does not occur in a diffuse or stochastic manner but follows an ordered spatial pattern that is restricted to the surfaces of the lesional bone. These results suggest that during RANKL inhibition the amount of intra-lesional bone trabecular surfaces is critical to the process of cell differentiation and to the skeletal improvement that FD patients may achieve during the treatment.\n                  <\/jats:p>","DOI":"10.1038\/s42003-026-10097-z","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:38:30Z","timestamp":1776875910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring bone formation mechanism and pattern during RANKL inhibition in a fibrous dysplasia mouse model"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0122-0155","authenticated-orcid":false,"given":"Giorgia","family":"Farinacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Coletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-5256","authenticated-orcid":false,"given":"Biagio","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Spica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tavanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Di Cristofano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-758X","authenticated-orcid":false,"given":"Samantha","family":"Donsante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Borsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anna","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-4509","authenticated-orcid":false,"given":"Alessandro","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ciarrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-7295","authenticated-orcid":false,"given":"Domenico","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-9211","authenticated-orcid":false,"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"10097_CR1","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein, L. S. et al. Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome. N. Engl. J. Med. 325, 1688\u20131695 (1991).","journal-title":"N. Engl. J. Med."},{"key":"10097_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03909-8","volume":"20","author":"B Palmisano","year":"2025","unstructured":"Palmisano, B. et al. Fibrous dysplasia\/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic\/translational research. Orphanet J. Rare Dis. 20, 414 (2025).","journal-title":"Orphanet J. Rare Dis."},{"key":"10097_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-S1-S3","volume":"7","author":"RD Chapurlat","year":"2012","unstructured":"Chapurlat, R. D. et al. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet. J. Rare Dis. 7, S3 (2012).","journal-title":"Orphanet. J. Rare Dis."},{"key":"10097_CR4","first-page":"155","volume":"12","author":"E Ippolito","year":"2003","unstructured":"Ippolito, E. et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J. Pediatr. Orthop. B 12, 155\u2013177 (2003).","journal-title":"J. Pediatr. Orthop. B"},{"key":"10097_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","volume":"187","author":"M Riminucci","year":"1999","unstructured":"Riminucci, M. et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J. Pathol. 187, 249\u2013258 (1999).","journal-title":"J. Pathol."},{"key":"10097_CR6","unstructured":"Siegal, G., Bloem, J., Cates, J. & Hameed, M. Soft Tissue and Bone Tumours. Fibrous Dysplasia WHO Classification of Tumours, Soft Tissue and Bone Tumours. Vol. 3 (IARC Press, Lyon, 2020)."},{"key":"10097_CR7","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2014-1371","volume":"99","author":"AM Boyce","year":"2014","unstructured":"Boyce, A. M. et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J. Clin. Endocrinol. Metab. 99, 4133\u20134140 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10097_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00223-020-00752-w","volume":"107","author":"A Corsi","year":"2020","unstructured":"Corsi, A. et al. Zoledronic acid in a mouse model of human fibrous dysplasia: ineffectiveness on tissue pathology, formation of \u201cgiant osteoclasts\u201d and pathogenetic implications. Calcif. Tissue Int. 107, 603\u2013610 (2020).","journal-title":"Calcif. Tissue Int."},{"key":"10097_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"10097_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada, T., Nakashima, T., Hiroshi, N. & Penninger, J. M. RANKL\u2013RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17\u201325 (2006).","journal-title":"Trends Mol. Med."},{"key":"10097_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1359\/jbmr.091036","volume":"25","author":"S Piersanti","year":"2010","unstructured":"Piersanti, S. et al. Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J. Bone Miner. Res. 25, 1103\u20131116 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jbmr.3602","volume":"34","author":"LF de Castro","year":"2019","unstructured":"de Castro, L. F. et al. Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden. J. Bone Miner. Res. 34, 290\u2013294 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR13","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/jbmr.3828","volume":"34","author":"B Palmisano","year":"2019","unstructured":"Palmisano, B. et al. RANKL inhibition in fibrous dysplasia of bone: a preclinical study in a mouse model of the human disease. J. Bone Miner. Res. 34, 2171\u20132182 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116301","volume":"156","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia. Bone 156, 116301 (2022).","journal-title":"Bone"},{"key":"10097_CR15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce, A. M. et al. Denosumab treatment for fibrous dysplasia. J. Bone Miner. Res. 27, 1462\u20131470 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1056\/NEJMc2214862","volume":"388","author":"LF de Castro","year":"2023","unstructured":"de Castro, L. F. et al. Safety and efficacy of denosumab for fibrous dysplasia of bone. N. Engl. J. Med. 388, 766\u2013768 (2023).","journal-title":"N. Engl. J. Med."},{"key":"10097_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41413-023-00311-7","volume":"12","author":"LF de Castro","year":"2024","unstructured":"de Castro, L. F. et al. RANKL inhibition reduces lesional cellularity and G\u03b1s variant expression and enables osteogenic maturation in fibrous dysplasia. Bone Res. 12, 10 (2024).","journal-title":"Bone Res."},{"key":"10097_CR18","doi-asserted-by":"publisher","first-page":"33814","DOI":"10.1074\/jbc.M607290200","volume":"281","author":"K Inoue","year":"2006","unstructured":"Inoue, K. et al. A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J. Biol. Chem. 281, 33814\u201333824 (2006).","journal-title":"J. Biol. Chem."},{"key":"10097_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/hmg\/ddm060","volume":"16","author":"RA Mosig","year":"2007","unstructured":"Mosig, R. A. et al. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum. Mol. Genet. 16, 1113\u20131123 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"10097_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41413-018-0035-6","volume":"6","author":"X Chen","year":"2018","unstructured":"Chen, X., Zhi, X., Wang, J. & Su, J. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 6, 34 (2018).","journal-title":"Bone Res."},{"key":"10097_CR21","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/jbmr.2267","volume":"29","author":"I Saggio","year":"2014","unstructured":"Saggio, I. et al. Constitutive expression of Gs\u03b1R201C in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history. J. Bone Miner. Res. 29, 2357\u20132368 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1359\/jbmr.2000.15.1.120","volume":"15","author":"P Bianco","year":"2000","unstructured":"Bianco, P. et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non\u2013McCune\u2013albright fibrous dysplasia of bone. J. Bone Miner. Res. 15, 120\u2013128 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1359\/jbmr.2003.18.7.1235","volume":"18","author":"A Corsi","year":"2003","unstructured":"Corsi, A. et al. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J. Bone Miner. Res. 18, 1235\u20131246 (2003).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/BF02375516","volume":"6","author":"I Oguro","year":"1988","unstructured":"Oguro, I. & Ozawa, H. The histochemical localization of acid phosphatase activity in BMU. J. Bone Miner. Metab. 6, 44\u201349 (1988).","journal-title":"J. Bone Miner. Metab."},{"key":"10097_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117047","volume":"181","author":"B Palmisano","year":"2024","unstructured":"Palmisano, B. et al. A pathogenic role for brain-derived neurotrophic factor (BDNF) in fibrous dysplasia of bone. Bone 181, 117047 (2024).","journal-title":"Bone"},{"key":"10097_CR26","doi-asserted-by":"publisher","first-page":"101058","DOI":"10.1016\/j.bonr.2021.101058","volume":"14","author":"ME Meier","year":"2021","unstructured":"Meier, M. E., van der Bruggen, W., van de Sande, M. A. J. & Appelman-Dijkstra, N. M. Regression of fibrous dysplasia in response to denosumab therapy: a report of two cases. Bone Rep. 14, 101058 (2021).","journal-title":"Bone Rep."},{"key":"10097_CR27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.4380","volume":"36","author":"ME Meier","year":"2020","unstructured":"Meier, M. E. et al. Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study. J. Bone Miner. Res. 36, 1729\u20131738 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR28","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00259-019-04657-1","volume":"47","author":"W van der Bruggen","year":"2020","unstructured":"van der Bruggen, W. et al. Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET\/CT. Eur. J. Nucl. Med. Mol. Imaging 47, 1527\u20131537 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10097_CR29","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1210\/jc.2017-02669","volume":"103","author":"DW Dempster","year":"2018","unstructured":"Dempster, D. W. et al. Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 103, 2498\u20132509 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10097_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41584-023-00935-3","volume":"19","author":"S Ferrari","year":"2023","unstructured":"Ferrari, S. & Langdahl, B. Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone. Nat. Rev. Rheumatol. 19, 307\u2013317 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10097_CR31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jbmr.2425","volume":"30","author":"C Remoli","year":"2015","unstructured":"Remoli, C. et al. Osteoblast-specific expression of the fibrous dysplasia (FD)\u2013causing mutation Gs\u03b1R201C produces a high bone mass phenotype but does not reproduce FD in the mouse. J. Bone Miner. Res. 30, 1030\u20131043 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/modpathol.2012.223","volume":"26","author":"F Tabareau-Delalande","year":"2013","unstructured":"Tabareau-Delalande, F. et al. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod. Pathol. 26, 911\u2013921 (2013).","journal-title":"Mod. Pathol."},{"key":"10097_CR33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/jbmr.4538","volume":"37","author":"D Farlay","year":"2020","unstructured":"Farlay, D. et al. Bone mineral and organic properties in postmenopausal women treated with denosumab for up to 10 years. J. Bone Miner. Res. 37, 856\u2013864 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.it.2019.09.006","volume":"40","author":"S Saw","year":"2019","unstructured":"Saw, S., Weiss, A., Khokha, R. & Waterhouse, P. D. Metalloproteases: on the watch in the hematopoietic niche. Trends Immunol. 40, 1053\u20131070 (2019).","journal-title":"Trends Immunol."},{"key":"10097_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0092-8674(04)00344-7","volume":"117","author":"X Yang","year":"2004","unstructured":"Yang, X. et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology. Cell 117, 387\u2013398 (2004).","journal-title":"Cell"},{"key":"10097_CR36","doi-asserted-by":"publisher","first-page":"e0227279","DOI":"10.1371\/journal.pone.0227279","volume":"15","author":"D Raimondo","year":"2020","unstructured":"Raimondo, D. et al. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gs\u03b1 correlates with hallmark histopathological changes seen in fibrous dysplastic bone. PLoS ONE 15, e0227279 (2020).","journal-title":"PLoS ONE"},{"key":"10097_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41413-022-00220-1","volume":"10","author":"B Palmisano","year":"2022","unstructured":"Palmisano, B. et al. Gs\u03b1R201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells. Bone Res. 10, 50 (2022).","journal-title":"Bone Res."},{"key":"10097_CR38","doi-asserted-by":"publisher","first-page":"116870","DOI":"10.1016\/j.bone.2023.116870","volume":"176","author":"B Palmisano","year":"2023","unstructured":"Palmisano, B., Riminucci, M. & Karsenty, G. Interleukin-6 signaling in osteoblasts regulates bone remodeling during exercise. Bone 176, 116870 (2023).","journal-title":"Bone"},{"key":"10097_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2\u201317 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"10097_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1158\/1078-0432.CCR-19-2356","volume":"26","author":"S Luminari","year":"2020","unstructured":"Luminari, S. et al. A gene expression\u2013based model to predict metabolic response after two courses of ABVD in Hodgkin lymphoma patients. Clin. Cancer Res. 26, 373\u2013383 (2020).","journal-title":"Clin. Cancer Res."},{"key":"10097_CR41","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.bonr.2021.101156","volume":"16","author":"A Persichetti","year":"2022","unstructured":"Persichetti, A. et al. Nanostring technology on Fibrous Dysplasia bone biopsies. a pilot study suggesting different histology-related molecular profiles. Bone Rep. 16, 101156 (2022).","journal-title":"Bone Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10097-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:06:30Z","timestamp":1786489590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10097-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10097"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10097-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.08.26.672317","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1088"}}